Samsung Ventures, established in 1999, is a corporate venture capital arm of Samsung Electronics, headquartered in Seoul, South Korea. The firm invests globally in emerging technology companies, with a focus on semiconductors, mobile services, internet, software, security, enterprise solutions, bioengineering, and medical sectors. Its investment portfolio spans early-stage startups to pre-IPO companies, with an annual investment budget of $250 million and over $1.8 billion under management. Samsung Ventures operates from key innovation hubs worldwide, including the San Francisco Bay Area, Boston, London, Tel Aviv, Bangalore, Tokyo, and Beijing, to identify and support pioneering startups in areas such as AI, robotics, augmented/virtual reality, and digital health.
Managing Director and Head of Samsung Ventures America, East Coast
Jinho Park
Investment Director
Wookyoung Park
Investment Director
Junho Yang
Investment Director
Chanwoo Yang
Investment Director
Il Seok Yoon
Chief Investment Officer
Jisu Yoon
Investment Director
Sung Eun Sarah Kim
Investment Director
Past deals in Health Diagnostics
C2N Diagnostics
Corporate Round in 2025
C2N Diagnostics, LLC is a privately held company focused on protein diagnostics and therapeutic discovery for progressive neurodegenerative diseases, particularly Alzheimer's disease. Founded in late 2007 by Drs. David Holtzman and Randall Bateman from Washington University School of Medicine, alongside LifeTech Research, the company is based at the Center for Emerging Technologies in St. Louis. C2N Diagnostics utilizes advanced mass spectrometry techniques to offer precise identification, quantification, and monitoring of proteins and biomolecules associated with neurological disorders. This innovative approach enables healthcare professionals to detect and characterize neurocognitive disorders more accurately, enhancing the potential for effective diagnosis and treatment strategies.
Pison
Venture Round in 2025
Pison Technology, Inc., established in 2016 and headquartered in Boston, Massachusetts, specializes in developing and marketing wearable devices. These devices are designed to capture and filter signals sent to the nervous system, primarily serving individuals with amyotrophic lateral sclerosis (ALS). Pison's innovative, non-invasive electroneurography (ENG) algorithms and sensor array technology aim to optimize cognitive and physiological capabilities through gesture control, with applications in cognitive enhancement, disease diagnosis, and improving overall quality of life.
adoc
Series B in 2024
adoc provides medical records, discount medical examination, check AI symptoms and compare hospital expenses services.
Natural Cycles
Series C in 2024
Natural Cycles is a digital health company that provides a contraceptive app designed to empower women in managing their reproductive health. The app utilizes an algorithm to analyze users' basal body temperature and other relevant data, such as luteinizing hormone levels, to determine fertility status throughout the menstrual cycle. By requiring daily temperature measurements with a basal thermometer, the app generates a color-coded calendar that informs users of their fertile days, allowing for informed decisions regarding unprotected sex. This non-invasive and non-hormonal approach enables women to plan or prevent pregnancies while avoiding the side effects associated with traditional contraceptive methods. Natural Cycles is at the forefront of digital contraception, offering a modern solution to female fertility tracking.
Subtle Medical
Series B in 2024
Subtle Medical, Inc. is a healthcare technology company based in Menlo Park, California, that specializes in developing AI-powered medical imaging software for clinical imaging centers and hospitals. Founded in 2017, the company offers products such as SubtleMR and SubtlePET, both of which are FDA cleared and CE marked. These technologies enhance image quality in magnetic resonance imaging (MRI) and positron emission tomography (PET) exams by reducing noise and increasing sharpness, ultimately improving workflow efficiency while ensuring patient safety. Subtle Medical also features SubtleGAD, a technology recognized by the Radiological Society of North America, which aims to make imaging exams safer. The company employs a vendor-agnostic AI infrastructure that integrates seamlessly with existing scanners, allowing imaging providers to serve more patients effectively by enhancing image acquisition without disrupting their current workflow. Through its innovations, Subtle Medical seeks to improve the quality, value, and accessibility of medical imaging while significantly lowering costs and radiation exposure.
Natural Cycles
Venture Round in 2023
Natural Cycles is a digital health company that provides a contraceptive app designed to empower women in managing their reproductive health. The app utilizes an algorithm to analyze users' basal body temperature and other relevant data, such as luteinizing hormone levels, to determine fertility status throughout the menstrual cycle. By requiring daily temperature measurements with a basal thermometer, the app generates a color-coded calendar that informs users of their fertile days, allowing for informed decisions regarding unprotected sex. This non-invasive and non-hormonal approach enables women to plan or prevent pregnancies while avoiding the side effects associated with traditional contraceptive methods. Natural Cycles is at the forefront of digital contraception, offering a modern solution to female fertility tracking.
Alodokter
Venture Round in 2022
Alodokter is a digital health platform based in Indonesia that offers a comprehensive range of services aimed at enhancing patient care. The platform facilitates telemedicine services, allowing patients to connect with qualified doctors for consultations. In addition to this, Alodokter provides users with credible health information, supportive communities, and detailed reference materials covering various health topics. By enabling appointment booking and offering resources about illnesses, treatments, and healthy living, Alodokter empowers individuals to make informed health decisions, particularly in emergency situations. The platform is designed to improve accessibility to quality healthcare information and professional medical support for users across Indonesia.
Goodoc
Series A in 2022
Goodoc is a Korean smartphone application designed to enhance access to medical services for users. The app provides reliable information about doctors, hospitals, and various medical services, including details on fees and contact numbers. By offering insights into medical and patient statistical data, as well as hospital operation programs, Goodoc aims to streamline the complexities involved in choosing medical services. This approach addresses the information asymmetry often faced by patients, enabling them to make informed decisions regarding their healthcare options.
DiaMonTech
Venture Round in 2022
DiaMonTech AG is a medical technology company based in Berlin, Germany, focused on developing non-invasive diagnostic devices for blood glucose monitoring. Founded in 2015, the company utilizes a proprietary laser-based photo-thermal detection technology to measure glucose levels without the need for blood draws or finger pricking, thereby offering a painless alternative for diabetes management. DiaMonTech's product lineup includes the D-BASE, a device designed for human trials, the D-pocket, a compact personal device for frequent glucose tracking, and the D-BAND, a wearable device that continuously monitors blood sugar levels. Through its innovative solutions, DiaMonTech aims to enhance the quality of life for individuals managing diabetes.
Hutom
Series B in 2022
Hutom operates a surgical service platform designed to enhance surgical practices through innovative digital solutions. Its platform focuses on improving diagnosis and managing patient complications by utilizing robotics and laparoscopic surgery techniques. It offers an interactive report that aids surgeons in refining their methods. The process begins with an intuitive, analytical diagnosis tailored to the patient's needs, followed by a simulated examination of the surgical procedure. This includes advanced surgical video processing, recognition, analysis, and prediction, along with the provision of 3D anatomical images and AI-driven surgical analysis reports. By integrating these technologies, Hutom enables medical professionals to address complications more effectively and improve patient outcomes.
adoc
Series A in 2021
adoc provides medical records, discount medical examination, check AI symptoms and compare hospital expenses services.
Alodokter
Venture Round in 2021
Alodokter is a digital health platform based in Indonesia that offers a comprehensive range of services aimed at enhancing patient care. The platform facilitates telemedicine services, allowing patients to connect with qualified doctors for consultations. In addition to this, Alodokter provides users with credible health information, supportive communities, and detailed reference materials covering various health topics. By enabling appointment booking and offering resources about illnesses, treatments, and healthy living, Alodokter empowers individuals to make informed health decisions, particularly in emergency situations. The platform is designed to improve accessibility to quality healthcare information and professional medical support for users across Indonesia.
Noom
Series F in 2021
Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.
Hutom
Series B in 2021
Hutom operates a surgical service platform designed to enhance surgical practices through innovative digital solutions. Its platform focuses on improving diagnosis and managing patient complications by utilizing robotics and laparoscopic surgery techniques. It offers an interactive report that aids surgeons in refining their methods. The process begins with an intuitive, analytical diagnosis tailored to the patient's needs, followed by a simulated examination of the surgical procedure. This includes advanced surgical video processing, recognition, analysis, and prediction, along with the provision of 3D anatomical images and AI-driven surgical analysis reports. By integrating these technologies, Hutom enables medical professionals to address complications more effectively and improve patient outcomes.
QSTAG
Series A in 2020
QSTAG Inc. is a South Korean company focused on developing and manufacturing disposable urine test strips and diagnostic kits designed for special marker diagnosis. Established in 2016 and based in Gunpo-si, the company offers a range of products, including QSCheck-UIS4, a urine test strip that utilizes a QR code application for health checks in humans and pets, as well as water pollution and gas leak testing. The QSCheck smart strip serves multiple diagnostic purposes, including pregnancy testing and disease diagnosis for both humans and animals. Additionally, QSTAG provides the QSReader application, which compiles and visualizes data from its diagnostic products. By leveraging immunological electrochemical biosensor technology, QSTAG aims to facilitate cost-effective and efficient self-health monitoring, enabling users to manage their health at home while seamlessly communicating results to healthcare providers.
Human API
Series C in 2020
Human API is a digital health data network that allows consumers to easily access and share their health information from various sources, including hospitals, electronic medical records, pharmacies, labs, and wearable devices. Founded in 2013 and based in San Mateo, California, the company connects to data from 90% of US hospitals and over 300 wellness applications. The platform employs a machine learning-powered data pipeline to standardize health data, making it more accessible and actionable for medical researchers and scientists. Importantly, it empowers consumers to maintain control over their personal health data, determining which companies can access their information. This streamlined approach addresses the challenges of fragmented health data sources, facilitating efficient data sharing and utilization in the healthcare ecosystem.
Fitpet
Series B in 2020
Fitpet is a developer of a veterinary application aimed at enhancing the quality of life for companion animals and their caregivers. The application utilizes technological advancements to monitor a pet's health status in real time through a comprehensive analysis of various parameters. This enables pet owners to better understand and manage their pets' health needs effectively. Fitpet's mission is to foster a sustainable and wholesome society for pets worldwide.
HurayPositive
Series B in 2020
HurayPositive Corp. is a healthcare and wellness innovation company based in Seoul, South Korea, founded in 2010. The company specializes in designing and developing applications that deliver healthcare services tailored to patients with chronic diseases. Its offerings include MyHealthNote, which focuses on diabetes care; National Health Screening Follow-up Services, aimed at monitoring health and improving lifestyle post-screening; and Active Aging Healthcare Service, which provides preventive measures by analyzing real-time behavioral changes in residential environments. Additionally, HurayPositive offers self-management solutions for dialysis, blood pressure, and weight, while also integrating mHealth, personal health records, genome analysis, and IT convergence services such as user interface and experience development.
Deep Medi
Venture Round in 2019
Deep Medi provides information and resources related to healthcare, particularly in the areas of medical research and clinical practise. They provide products that include API, haley, and, always, BP.
Luple
Pre Seed Round in 2019
Living an energetic life after having a good sleep is out very fundamental right. Many people, however, with various reasons, do not achieve this right ; some people suffers taking sleeping pills due to insomnia, while others overdose caffeine just to get a little bit of energy. We want to lend a hand to those people who suffers in their daily lives. We want people to have a good sleep, to have a fresh morning, and to have a healthy and happy life with our Digital Therapeutics Device & Solution.
Fitpet
Venture Round in 2019
Fitpet is a developer of a veterinary application aimed at enhancing the quality of life for companion animals and their caregivers. The application utilizes technological advancements to monitor a pet's health status in real time through a comprehensive analysis of various parameters. This enables pet owners to better understand and manage their pets' health needs effectively. Fitpet's mission is to foster a sustainable and wholesome society for pets worldwide.
Noom
Series E in 2019
Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.
Breathings
Venture Round in 2019
BreaThings specializes in developing breath analysis devices aimed at enhancing respiratory health and performance. Their innovative technology provides users with organized data and statistics that facilitate intelligent training, helping individuals improve their overall performance in daily tasks. Additionally, the devices recommend customized breathing exercises tailored to strengthen respiratory function and address various respiratory conditions. Through its focus on breathing, BreaThings aims to empower users with the tools necessary for better respiratory health and enhanced daily productivity.
Zhangshang Tangyi
Series C in 2019
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.
Hutom
Series A in 2018
Hutom operates a surgical service platform designed to enhance surgical practices through innovative digital solutions. Its platform focuses on improving diagnosis and managing patient complications by utilizing robotics and laparoscopic surgery techniques. It offers an interactive report that aids surgeons in refining their methods. The process begins with an intuitive, analytical diagnosis tailored to the patient's needs, followed by a simulated examination of the surgical procedure. This includes advanced surgical video processing, recognition, analysis, and prediction, along with the provision of 3D anatomical images and AI-driven surgical analysis reports. By integrating these technologies, Hutom enables medical professionals to address complications more effectively and improve patient outcomes.
Breathings
Seed Round in 2017
BreaThings specializes in developing breath analysis devices aimed at enhancing respiratory health and performance. Their innovative technology provides users with organized data and statistics that facilitate intelligent training, helping individuals improve their overall performance in daily tasks. Additionally, the devices recommend customized breathing exercises tailored to strengthen respiratory function and address various respiratory conditions. Through its focus on breathing, BreaThings aims to empower users with the tools necessary for better respiratory health and enhanced daily productivity.
Lillycover Co.
Seed Round in 2016
Lillycover Co., Ltd., founded in 2016 and headquartered in Daegu, South Korea, specializes in personalized beauty solutions for skincare. The company has developed a skin diagnosis and treatment device that helps users understand their unique skin types through actual skin data collected from various countries. Its portable skin diagnosis and management device enables users to assess key skin attributes, including pores, wrinkles, sensitivity, and oil-water balance, allowing for effective management of their skincare results.
Noom
Series C in 2016
Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.
Welldoc
Series B in 2015
Welldoc, Inc. specializes in developing technology solutions for chronic disease management, focusing primarily on diabetes care. Its flagship product, the DiabetesManager platform, allows patients and healthcare providers to coordinate care effectively, promoting self-management and adherence to treatment. This platform includes features such as personalized coaching, medication reminders, out-of-bound alerts, and cloud-based analytics for tracking health metrics. Additionally, Welldoc offers BlueStar, a mobile prescription therapy that provides real-time guidance for diabetes management and clinical decision support for healthcare professionals. The company collaborates with various stakeholders, including payors, employers, pharmaceutical firms, and healthcare systems, to ensure its solutions integrate seamlessly into existing workflows. Founded in 2005 and based in Baltimore, Maryland, with additional offices in Wilmington, Delaware, and Bengaluru, India, Welldoc aims to transform digital health management through innovative technology and artificial intelligence.
dacadoo
Series A in 2015
dacadoo AG is a technology company based in Zurich, Switzerland, that focuses on digital health engagement and health risk quantification. Founded in 2010, dacadoo provides a mobile-first health management platform designed to motivate users to adopt and maintain healthy lifestyle habits. The platform utilizes behavioral science, artificial intelligence, and gamification to create personalized engagement experiences. Its patented Health Score, derived from extensive clinical data, enables users to measure their health in real time. dacadoo also offers customizable solutions for enterprise clients, including health and life insurance companies, wellness organizations, and employers seeking to enhance workplace health promotion. The technology is available in 15 languages and can be implemented as a branded solution or integrated into existing customer products via an API. With offices in Boston and Sydney, dacadoo serves a global clientele across Europe, the Middle East, North America, Latin America, and Asia Pacific.
Noom
Series B in 2015
Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.
EarlySense
Series F in 2015
EarlySense Ltd. specializes in developing advanced patient monitoring systems for healthcare facilities, including hospitals and rehabilitation centers. The company offers a range of products, such as the EarlySense System, which provides continuous monitoring of heart rate, respiratory rate, and patient motion, enabling healthcare teams to detect early signs of patient deterioration and prevent falls and pressure ulcers. Additionally, the Central Display Station allows nurses to supervise multiple patients effectively, while the contact-free consumer health monitor, known as LIVE, provides valuable health information to users and their caregivers. EarlySense's technology is employed in various medical settings, including surgical wards, oncology, and long-term care facilities. Founded in 2004 and headquartered in Ramat Gan, Israel, with a marketing office in Woburn, Massachusetts, the company has formed partnerships to enhance its product offerings and expand its market reach.
Noom
Series A in 2013
Noom, Inc. is a New York-based company that specializes in mobile health coaching through a psychology-based digital health platform. Founded in 2008, Noom develops a mobile application that combines evidence-based curricula, personalized coaching, and data-driven insights to help users achieve their health and wellness goals, including weight management and chronic disease prevention. The platform offers scalable tools for exercise and nutrition coaching, utilizing artificial intelligence to facilitate behavioral change. Recognized for its innovative approach, Noom has received multiple grants from the National Institutes of Health and was the first mobile application certified by the Centers for Disease Control as a diabetes prevention program. The company also caters to business enterprises, supporting organizations in promoting employee health. With additional offices in Seoul and Tokyo, Noom continues to expand its global reach and impact on personal health management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.